Your Source for NPR News & Music

SCIENCE STUDIO: Metronomic Chemotherapy

Your browser doesn’t support HTML5 audio

***Original Broadcast Date: February 15, 2015***

Keith & Russ welcome Robert S. Kerbel, senior scientist at the Sunnybrook Health Sciences Centre, Toronto, Canada.  Kerbel explains how regular chemotherapy for cancer patients often involves a "maximum tolerated dose" of treatment, which often taxes the patient and requires several days of recovery before the next treatment.  With metronomic chemotherapy, researchers hope to lower the dose of drugs and make the dosage more frequent.  

Aired July 23, 2017

  • Facebook
  • Twitter
  • LinkedIn
  • Email
Related Stories
  1. Texas charging another large group of migrants with “riot participation”
  2. El Pasoans catch glimpse of solar eclipse
  3. Texas criminally charges more than 200 migrants involved in alleged “riot” at the border
  4. Lebanese migrant allegedly tied to terrorist group appears in federal court with a black eye